Risk of Kidney Failure, Death, and Cardiovascular Events After Lower Limb Complications in Patients With CKD.
CKD
diabetic foot
peripheral arterial disease
renal dialysis
renal insufficiency
Journal
Kidney international reports
ISSN: 2468-0249
Titre abrégé: Kidney Int Rep
Pays: United States
ID NLM: 101684752
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
24
07
2020
revised:
03
11
2020
accepted:
10
11
2020
entrez:
22
2
2021
pubmed:
23
2
2021
medline:
23
2
2021
Statut:
epublish
Résumé
Lower limb complications are major adverse events in patients with peripheral artery disease (PAD) and chronic kidney disease (CKD). These complications can lead to morbidity, disability, reduced quality of life, and higher health care costs. We sought to determine how interim lower limb complications modify the subsequent risk of progression to kidney failure, all-cause mortality before kidney failure, and cardiovascular (CV) events in a cohort of patients with CKD stages G3 to G5. We performed a retrospective cohort study using patient-level data obtained by linking several administrative databases from Manitoba, Canada. We used Fine and Gray regression models for the primary outcomes of (1) kidney failure adjusted for the competing risk of all-cause mortality, (2) death before kidney failure, and (3) cardiovascular-related hospitalization with the competing risk of non-CV death. A total of 92,618 patients were included in the final cohort, with a median follow-up time of 2.56 years. Compared with patients who did not experience an interim lower limb complication, there was a higher risk of kidney failure (adjusted hazard ratio [HR] 2.51, 95% confidence interval [CI] 2.10-3.00), all-cause mortality before kidney failure (adjusted HR 2.73, 95% CI 2.55-2.92), and CV events (adjusted HR 2.12, 95% CI 1.90-2.38). Interim lower limb complications are associated with an increased risk of kidney failure, all-cause mortality before kidney failure, and cardiovascular-related hospitalization. Clinical trials of screening and treatment strategies for patients with CKD at risk for lower limb complications may help determine optimal strategies to manage this risk.
Identifiants
pubmed: 33615063
doi: 10.1016/j.ekir.2020.11.010
pii: S2468-0249(20)31721-6
pmc: PMC7879126
doi:
Types de publication
Journal Article
Langues
eng
Pagination
381-388Subventions
Organisme : AHRQ HHS
ID : R01 HS018574
Pays : United States
Informations de copyright
© 2021 Published by Elsevier, Inc., on behalf of the International Society of Nephrology.
Références
Intern Med J. 2012 Jun;42(6):e120-8
pubmed: 21999812
J Vasc Surg. 1995 Sep;22(3):280-5; discussion 285-6
pubmed: 7674471
J Am Soc Nephrol. 2007 Feb;18(2):629-36
pubmed: 17215445
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Intern Med J. 2008 May;38(5):314-20
pubmed: 18005131
J Vasc Surg. 2013 Oct;58(4):966-71
pubmed: 23769941
Curr Diab Rep. 2010 Aug;10(4):283-90
pubmed: 20532700
Am J Kidney Dis. 2002 Sep;40(3):566-75
pubmed: 12200809
Diabetes Care. 2008 Jul;31(7):1331-6
pubmed: 18390800
J Vasc Surg. 2013 Nov;58(5):1291-9
pubmed: 23810259
CMAJ. 2013 Jun 11;185(9):E417-23
pubmed: 23649413
Circulation. 2014 Aug 5;130(6):458-65
pubmed: 24899688
J Vasc Surg. 2007 May;45(5):944-52
pubmed: 17391900
Nephrol Dial Transplant. 2006 Nov;21(11):3207-10
pubmed: 16877485
J Vasc Surg. 2015 Aug;62(2):406-11
pubmed: 25937604
Circulation. 2016 Jun 14;133(24):2593-8
pubmed: 27297351
Lancet. 2005 Nov 12;366(9498):1719-24
pubmed: 16291066
Adv Chronic Kidney Dis. 2014 Nov;21(6):460-71
pubmed: 25443571
Diabetes Res Clin Pract. 2005 Oct;70(1):31-7
pubmed: 16126121
Diabetes Care. 2010 Aug;33(8):1811-6
pubmed: 20484126